# Phase 10.4 Dataset and Methodology Review

## Source Files Inspected
- `src/create_splits.py`
- `src/train.py`
- `src/finetune.py`
- `src/evaluate.py`
- `app/app.py`
- `README.md`
- Authoritative evaluation reports (`consolidated_evaluation_report.md`, `final_metrics_summary.md`, `error_analysis_report.md`)

## Dataset Documentation Completed
The `reports/dataset_and_methodology.md` file was successfully generated. It comprehensively details the HAM10000 dataset structure, the original seven classes, and the significance of `lesion_id` metadata.

## Binary Mapping Verified
The mapping of non-malignant (`NV`, `BKL`, `DF`, `VASC`) and malignant-suspicious (`MEL`, `BCC`, `AKIEC`) classes was explicitly documented as a machine-learning target without making clinical diagnostic claims.

## Splitting Methodology Verified
Confirmed the usage of `GroupShuffleSplit` on `lesion_id` to prevent data leakage. Documented the approximate 70/15/15 splits resulting in the exact 1494-image held-out test set.

## Preprocessing Verified
Explicitly distinguished between Training preprocessing (augmentations: RandomHorizontalFlip, RandomVerticalFlip, RandomRotation(20), ColorJitter, Resize(224x224), ToTensor, ImageNet Normalization) and the deterministic Validation/Test/Inference preprocessing (Resize(224x224), ToTensor, Normalization).

## Training Methodology Verified
Documented the initial training configuration (EfficientNet-B0, 3 epochs, AdamW lr=0.0001, BCEWithLogitsLoss with positive class weight, Batch Size 16).

## Fine-Tuning Methodology Verified
Documented the fine-tuning phase (unfreezing final layers, 3 epochs, reduced AdamW lr=0.00001) and model selection via best Validation ROC-AUC. 

## Evaluation Methodology Verified
Incorporated the verified performance metrics (ROC-AUC 85.37%, Accuracy 68.47%, F1 55.10%, Recall 90.88%, Specificity 62.41%, Precision 39.53%) and confusion matrix counts, re-emphasizing that this evaluates statistical output and not clinical performance. Error analysis and threshold analysis logic were similarly documented.

## Limitations Documented
Explicit limitations were included regarding binary simplification, dataset characteristics, the non-clinical nature of the 0.50 threshold, class imbalance, and the lack of included raw data/checkpoints.

## README Link Added
Added a concise link directing users to the `dataset_and_methodology.md` file within the `Methodology` section of `README.md`.

## Safety-Language Audit
Reviewed the new documentation and `README.md` updates. Successfully excluded inappropriate usage of medical validation terms (diagnosis, medically safe, cancer detected). Employed safe phrasing (model output, estimated probability, research prototype). 

## Factual Consistency Check
All documented facts align perfectly with the python implementation logic in `src/` and `app/` files, as well as previously verified evaluation reports.

## Files Changed
- `reports/dataset_and_methodology.md` (Created)
- `reports/phase10_4_methodology_review.md` (Created)
- `README.md` (Updated)

## Tests Performed
- `python -m py_compile app/app.py`
- `git diff -- README.md`
- `git status`

## Confirmation
**Confirmed:** No changes were made to model weights, architecture, inference mathematics, data splits, or evaluation artifacts. This phase was purely documentation-focused.
